Please provide your email address to receive an email when new articles are posted on . Testing revealed significant cognitive differences between patients with Alzheimer’s or dementia and healthy ...

Quanterix QTRX recently announced the submission of a 510(k) premarket notification to the FDA for its multi-analyte ...

Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer the only blood test cleared by the U.S. Food and Drug Administration to aid ...

Switzerland-based Roche this week said it has received U.S. regulatory clearance for an Alzheimer’s blood test. This test is used in primary care offices for a patient’s initial assessment of ...

Should I ask my primary care physician for a cognitive assessment during my physical exam? According to a March 2019 report by the Alzheimer’s Association, 82% of seniors believe it is important to ...

Early recognition of cognitive decline in primary care allows for improved management of mild cognitive impairment and dementia in aging populations.

The tablet-based TabCAT tool demonstrates strong convergent validity with traditional tests for early-onset Alzheimer disease (EOAD).

Compared with sham treatment, personalised repetitive transcranial magnetic stimulation (rTMS) of the precuneus over 52 weeks led to a reduction in cognitive decline by 52% and functional decline by ...

Alzheimer’s disease is diagnosed with multiple types of tests that also help to rule out other possible conditions with similar symptoms. You may have blood and urine tests, memory function tests, and ...